Skip to main content
main-content

Zeitschrift

Annals of Hematology

Annals of Hematology 3/2017

Ausgabe 3/2017

Inhaltsverzeichnis ( 30 Artikel )

09.12.2016 | Original Article | Ausgabe 3/2017 Open Access

Polymorphisms of the TGF-β1 gene and the risk of acquired aplastic anemia in a Chinese population

Xue-hong Liang, Liucheng Rong, Guangsheng He, Hailong He, Shengyun Lin, Yan Yang, Yao Xue, Yongjun Fang

14.12.2016 | Original Article | Ausgabe 3/2017

GM-CSF treatment is not effective in congenital neutropenia patients due to its inability to activate NAMPT signaling

Corinna Koch, Bardia Samareh, Tatsuya Morishima, Perihan Mir, Lothar Kanz, Cornelia Zeidler, Julia Skokowa, Karl Welte

18.10.2016 | Original Article | Ausgabe 3/2017

Acute promyelocytic leukaemia is highly frequent among acute myeloid leukaemias in Brazil: a hospital-based cancer registry study from 2001 to 2012

Luiz Claudio Santos Thuler, Maria S. Pombo-de-Oliveira

23.12.2016 | Original Article | Ausgabe 3/2017

Fractionated gemtuzumab ozogamicin combined with intermediate-dose cytarabine and daunorubicin as salvage therapy in very high-risk AML patients: a bridge to reduced intensity conditioning transplant?

Etienne Paubelle, Sophie Ducastelle-Leprêtre, Hélène Labussière-Wallet, Franck Emmanuel Nicolini, Fiorenza Barraco, Adriana Plesa, Gilles Salles, Eric Wattel, Xavier Thomas

27.12.2016 | Original Article | Ausgabe 3/2017

Real world epidemiology of myeloproliferative neoplasms: a population based study in Korea 2004–2013

Ja Min Byun, Young Jin Kim, Taemi Youk, John Jeongseok Yang, Jongha Yoo, Tae Sung Park

20.10.2016 | Original Article | Ausgabe 3/2017

JAK2V617F and calreticulin mutations in recurrent venous thromboembolism: results from the EDITH prospective cohort

Jean-Christophe Ianotto, Aurélie Chauveau, Dominique Mottier, Valérie Ugo, Christian Berthou, Eric Lippert, Aurélien Delluc

26.11.2016 | Original Article | Ausgabe 3/2017

Ruxolitinib in clinical practice for primary and secondary myelofibrosis: an analysis of safety and efficacy of Gruppo Laziale of Ph-negative MPN

Massimo Breccia, Alessandro Andriani, Marco Montanaro, Elisabetta Abruzzese, Francesco Buccisano, Michele Cedrone, Antonietta Centra, Nicoletta Villivà, Francesca Celesti, Malgorzata Monica Trawinska, Fulvio Massaro, Ambra Di Veroli, Barbara Anaclerico, Gioia Colafigli, Matteo Molica, Antonio Spadea, Luca Petriccione, Giuseppe Cimino, Roberto Latagliata

06.12.2016 | Original Article | Ausgabe 3/2017

Bone marrow microvessel density and plasma angiogenic factors in myeloproliferative neoplasms: clinicopathological and molecular correlations

Danijela Lekovic, Mirjana Gotic, Radek Skoda, Bojana Beleslin-Cokic, Natasa Milic, Olivera Mitrovic-Ajtic, Ronny Nienhold, Dijana Sefer, Tijana Suboticki, Marijana Buac, Dragana Markovic, Milos Diklic, Vladan P. Cokic

29.12.2016 | Original Article | Ausgabe 3/2017

Clinico-biological characteristics and outcome of hepatitis C virus-positive patients with diffuse large B-cell lymphoma treated with immunochemotherapy

Ivan Dlouhy, Miguel Á. Torrente, Sabela Lens, Jordina Rovira, Laura Magnano, Eva Giné, Julio Delgado, Olga Balagué, Antonio Martínez, Elías Campo, Xavier Forns, José M. Sánchez-Tapias, Armando López-Guillermo

07.12.2016 | Original Article | Ausgabe 3/2017

Prognosis of patients with peripheral T cell lymphoma who achieve complete response after CHOP/CHOP-like chemotherapy without autologous stem cell transplantation as an initial treatment

Hideaki Kitahara, Dai Maruyama, Akiko Miyagi Maeshima, Shinichi Makita, Ken-ichi Miyamoto, Suguru Fukuhara, Wataru Munakata, Tatsuya Suzuki, Yukio Kobayashi, Kinuko Tajima, Takashi Terauchi, Hiroaki Kurihara, Hirokazu Taniguchi, Norio Komatsu, Kensei Tobinai

24.12.2016 | Original Article | Ausgabe 3/2017

BeEAM conditioning with bendamustine-replacing BCNU before autologous transplantation is safe and effective in lymphoma patients

Stefanie Gilli, Urban Novak, Behrouz Mansouri Taleghani, Gabriela M. Baerlocher, Kurt Leibundgut, Yara Banz, Thilo Zander, Daniel Betticher, Thomas Egger, Daniel Rauch, Thomas Pabst

10.01.2017 | Original Article | Ausgabe 3/2017

Bortezomib-containing regimens (BCR) for the treatment of non-transplant eligible multiple myeloma

Victor H Jimenez-Zepeda, Peter Duggan, Paola Neri, Jason Tay, Nizar J Bahlis

02.12.2016 | Original Article | Ausgabe 3/2017

Improved clinical outcomes for multiple myeloma patients treated at a single specialty clinic

Ariana Berenson, Suzie Vardanyan, Michael David, James Wang, Nika Manik Harutyunyan, Jillian Gottlieb, Ran Halleluyan, Tanya M. Spektor, Kyle A. Udd, Shahrooz Eshaghian, Youram Nassir, Benjamin Eades, Regina Swift, James R. Berenson

08.12.2016 | Original Article | Ausgabe 3/2017

Outcomes of multiple myeloma patients receiving bortezomib, lenalidomide, and carfilzomib

Ariana Berenson, Suzie Vardanyan, Michael David, James Wang, Nika Manik Harutyunyan, Jillian Gottlieb, Ran Halleluyan, Tanya M. Spektor, Kyle A. Udd, Shahrooz Eshaghian, Youram Nassir, Benjamin Eades, Regina Swift, James R. Berenson

24.12.2016 | Original Article | Ausgabe 3/2017

Comparison of engraftment following different stem cell mobilization modalities in patients with multiple myeloma treated with a uniform induction regimen containing bortezomib, cyclophosphamide and dexamethasone

Noam Benyamini, Irit Avivi, Eldad J. Dann, Tsila Zuckerman, Noa Lavi, Tami Katz

06.01.2017 | Original Article | Ausgabe 3/2017

Outcome of allogeneic hematopoietic stem cell transplantation in adult patients with acute myeloid leukemia harboring trisomy 8

Takaaki Konuma, Tadakazu Kondo, Takuya Yamashita, Naoyuki Uchida, Takahiro Fukuda, Yukiyasu Ozawa, Kazuteru Ohashi, Hiroyasu Ogawa, Chiaki Kato, Satoshi Takahashi, Heiwa Kanamori, Tetsuya Eto, Chiaki Nakaseko, Akio Kohno, Tatsuo Ichinohe, Yoshiko Atsuta, Akiyoshi Takami, Shingo Yano, Adult Acute Myeloid Leukemia Working Group of the Japan Society for Hematopoietic Cell Transplantation (JSHCT)

01.12.2016 | Original Article | Ausgabe 3/2017

Similar outcome after allogeneic stem cell transplantation with a modified FLAMSA conditioning protocol substituting 4 Gy TBI with treosulfan in an elderly population with high-risk AML

Udo Holtick, Marco Herling, Natali Pflug, Geothy Chakupurakal, Silke Leitzke, Dominik Wolf, Michael Hallek, Christof Scheid, Jens M. Chemnitz

26.12.2016 | Original Article | Ausgabe 3/2017 Open Access

Fibrinolysis in patients with a mild-to-moderate bleeding tendency of unknown cause

Johanna Gebhart, Sylvia Kepa, Stefanie Hofer, Silvia Koder, Alexandra Kaider, Alisa S. Wolberg, Helmuth Haslacher, Peter Quehenberger, Ernst Eigenbauer, Simon Panzer, Christine Mannhalter, Ingrid Pabinger

16.11.2016 | Letter to the Editor | Ausgabe 3/2017

Potential value of FDG PET-CT in diagnosis and follow-up of TAFRO syndrome

Fatemeh Behnia, Saeed Elojeimy, Manuela Matesan, David C. Fajgenbaum

03.12.2016 | Letter to the Editor | Ausgabe 3/2017

Role of complexity of variant Philadelphia chromosome in chronic myeloid leukemia in the era of tyrosine kinase inhibitor therapy

Zimu Gong, Lan Zheng, Zhenya Tang, Zi Chen, Wei Wang, Shi Bai, Guilin Tang, L. Jeffrey Medeiros, Shimin Hu

06.11.2016 | Letter to the Editor | Ausgabe 3/2017

Evidence for a role of decitabine in the treatment of myeloid sarcoma

Max Gornicec, Albert Wölfler, Susanne Stanzel, Heinz Sill, Armin Zebisch

15.12.2016 | Letter to the Editor | Ausgabe 3/2017

Sequential treatment with thrombopoietin-receptor agonists (TPO-RAs) in immune thrombocytopenia (ITP): experience in our center

Karla Javier González, Sebastian Ortiz Zuluaga, Carolina Villegas DaRos, Pedro Pérez Rodríguez, Antonio Cerveró Martí

03.01.2017 | Letter to the Editor | Ausgabe 3/2017

Cold agglutinin disease complicated by acrocyanosis and necrosis

Gareth P. Gregory, Ann Farrell, Susan Brown

20.10.2016 | Letter to the Editor | Ausgabe 3/2017

Cyclin A2 as a potential differential marker of splenic diffuse red pulp small B-cell lymphoma: a report of the first case

Khaoula Ben Younes, Raoudha Doghri, Karima Mrad, Neila Ben Romdhane, Fatma Ben Aissa-Fennira

12.11.2016 | Letter to the Editor | Ausgabe 3/2017

Radiologic and molecular remission of follicular T cell lymphoma treated with lenalidomide

Yok-Lam Kwong

12.11.2016 | Letter to the Editor | Ausgabe 3/2017

Intravascular lymphoma: look through the small vessels

Concepción Prats-Martín, Emilio Franco-Macías, Rosario M. Morales-Camacho, Olga Pérez, M. Teresa Vargas, Fátima de la Cruz Vicente, Juan J. Borrero, Ricardo Bernal, José A. Pérez-Simón

18.11.2016 | Letter to the Editor | Ausgabe 3/2017

Presence of risk factors does not affect outcome in early stage pediatric Hodgkin lymphoma treated with ABVD

Sainath Bhethanabhotla, Sameer Bakhshi

08.12.2016 | Letter to the Editor | Ausgabe 3/2017

Late isolated intraocular relapse of a systemic diffuse large B-cell lymphoma detected by flow cytometry

Edurne Sarrate, Marc Sorigue, Miriam Carbajal, Inmaculada Portal, Juan-Manuel Sancho, Jordi Juncà

07.11.2016 | Letter to the Editor | Ausgabe 3/2017

Rivaroxaban for heparin-induced thrombocytopenia: adding to the evidence

Shin Yeu Ong, Yun Ann Chin, Hein Than, Chuen Wen Tan, Eng Soo Yap, Wan Hui Wong, Heng Joo Ng

14.11.2016 | Letter to the Editor | Ausgabe 3/2017

Reversion of serum VZV-IgG antibody preceding disseminated visceral varicella zoster after hematopoietic stem cell transplantation

Sayaka Arakawa, Hidenori Kage, Haruka Chino, Munetoshi Hinata, Akimasa Hayashi, Takashi Toya, Satoshi Noguchi, Tetsuo Ushiku, Yasuhiro Yamauchi, Mineo Kurokawa, Masashi Fukayama, Takahide Nagase

Aktuelle Ausgaben

Neu im Fachgebiet Onkologie

Mail Icon II Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update Onkologie und bleiben Sie gut informiert – ganz bequem per eMail.

Bildnachweise